İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

PELİN MUTLU

PROFESÖR

ANKARA ÜNİVERSİTESİ BİYOTEKNOLOJİ ENSTİTÜSÜ BİYOTEKNOLOJİ ANABİLİM DALI

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Biyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 46
  • Proje 0
  • Kitap 0
  • Bildiri 46
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 15 Q2 18 Q3 5 Q4 2
WoS (JCR) Q1 4 Q2 18 Q3 12 Q4 6
TR Index 3 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 1
Üst %10 makale 6
Ort. yüzdelik 65.5%
Üst %1 payı 2.6%
Üst %10 payı 15.8%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 46 yayın

Scopus (SJR)
Q1 15 Q2 18 Q3 5 Q4 2
WoS (JCR)
Q1 4 Q2 18 Q3 12 Q4 6
TR Index
3 makale

Makale listesi

  1. 2025 Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer Archiv der Pharmazie DOI 10.1002/ardp.70015 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.0%
  2. 2025 Usnic Acid induces dual-pathway apoptosis in SKOV-3 ovarian cancer cells via PARP1 inhibition and MAPK pathway activation Human & Experimental Toxicology DOI 10.1177/09603271251409541 YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.7%
  3. 2025 Nanostructured 316L Stainless Steel Stent Surfaces Improve Corrosion Resistance, and Enhance Endothelization and Hemocompatibility Advanced Materials Interfaces DOI 10.1002/admi.202400968 YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.2%
  4. 2025 Design, Synthesis, Molecular Docking, Dynamics Simulation, and Biological Evaluation of Novel Thiazolidinedione Derivatives Against Breast Cancer with Apoptosis-Inducing Activity ACS Omega DOI 10.1021/acsomega.5c07713 YÖKSİS SJR Q1 JCR Q2 OpenAlex 69.2%
  5. 2024 Application of Inorganic Nanomaterials in Transdermal and Topical Medications: Influential Parameters, Opportunities and Challenges Comments on Inorganic Chemistry DOI 10.1080/02603594.2024.2323450 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.2%
  6. 2024 Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins Journal of Chemotherapy DOI 10.1080/1120009X.2024.2345454 YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.3%
  7. 2024 Synthesis, Anticancer Activity, and In Silico Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer ACS Omega DOI 10.1021/acsomega.3c09411 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.3%
  8. 2023 Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients International Immunopharmacology DOI 10.1016/j.intimp.2023.111011 YÖKSİS SJR Q1 JCR Q1 OpenAlex 51.6%
  9. 2023 Investigation of the Therapeutic Effects of Palbociclib Conjugated Magnetic Nanoparticles on Different Types of Breast Cancer Cell Lines Springer Science and Business Media LLC DOI 10.1007/s12195-022-00758-4 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.1%
  10. 2023 Identification of Single-nucleotide Alterations in MAP3K8 Gene in a Turkish Head and Neck Squamous Cell Carcinoma Patient Group Turkish Journal of Oncology DOI 10.5505/tjo.2023.3804 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 10.4%
  11. 2022 Identification of Mitochondrial DNA Gene Mutations in a Turkish Head and Neck Squamous Cancer Patient Group Akademi Doktorlar Yayinevi DOI 10.4999/uhod.226394 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 7.9%
  12. 2022 Vancomycin Containing PDLLA and PLGA/β-TCP Inhibit Biofilm Formation but Do Not Stimulate Osteogenic Transformation of Human Mesenchymal Stem Cells Frontiers Media SA DOI 10.3389/fsurg.2022.885241 YÖKSİS SJR Q2 JCR Q3 OpenAlex 71.6%
  13. 2022 Development of a microfluidic platform to maintain viability of micro-dissected tumor slices in culture BIOMICROFLUIDICS DOI 10.1063/5.0087532 YÖKSİS SJR Q2 JCR Q2 OpenAlex 35.0%
  14. 2022 NEK6 gene silencing using siRNA for overcome multidrug resistance in chronic myeloid leukemia cells Avrasya Arastirma Gelistirme Bilim ve Teknoloji Merkezi Limited Sirketi DOI 10.51539/biotech.996367 YÖKSİS OpenAlex 35.4%
  15. 2021 Design, synthesis, molecular docking and ADME studies of novel indole-thiazolidinedione derivatives and their antineoplastic activity as CDK6 inhibitors New Journal of Chemistry DOI 10.1039/d1nj02808a YÖKSİS SJR Q1 JCR Q2 OpenAlex 69.1%
  16. 2020 Evaluation of methylation profiles of an epidermal growth factor receptor gene in a head and neck squamous cell carcinoma patient group Balkan Journal of Medical Genetics DOI 10.2478/bjmg-2020-0025 YÖKSİS SJR Q4 JCR Q4 OpenAlex 11.7%
  17. 2020 Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/1871520620666200310091026 YÖKSİS SJR Q3 JCR Q3 OpenAlex 66.6%
  18. 2014 Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy Biomedicine & Pharmacotherapy DOI 10.1016/j.biopha.2014.04.003 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 90.5%
  19. 2014 Different types of cell cycle and apoptosis related gene expressions alter in corticosteroid vincristine and melphalan resistant U 266 multiple myeloma cell lines Turkish Journal of Hematology DOI 10.4274/tjh.2013.0231 YÖKSİS OpenAlex 63.9%
  20. 2014 The 137G C polymorphism in interleukin 18 gene promoter contributes to chronic lymphocytic and chronic myelogenous leukemia risk in Turkish patients Turkish Journal of Hematology DOI 10.4274/tjh.2014.0126 YÖKSİS OpenAlex 56.2%

Akademisyenlere dön